Conquering Diseases

Investigational Study for Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia


Seeking male & female patients 1-22 years of age who have been diagnosed with acute prolymphocytic leukemia (APL).


The main goal of this study is to find out if completely removing or reducing the amount of anthracycline chemotherapy used in standard APL treatment, and adding arsenic trioxide, will reduce some of the long-term side effects while maintaining a good cure rate.

What we're hoping for

We are hoping to shorten the duration of treatment and reduce the long term side effects.

Additional Information Identifier: NCT02101853

 Principal Investigator

Christopher  Keuker, MD

UMass Memorial Health Care

 Study Contact

Pediatrics Hem-Oncology  Research Center



UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655